Robeco Institutional Asset Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,765
Closed -$769K 1030
2023
Q2
$769K Sell
20,765
-46,308
-69% -$1.61M ﹤0.01% 811
2023
Q1
$2.09M Buy
67,073
+49,711
+286% +$1.6M 0.01% 681
2022
Q4
$517K Buy
17,362
+16,755
+2,760% +$600K ﹤0.01% 833
2022
Q3
$23K Buy
+607
New +$30.4K ﹤0.01% 929

Other funds holding FLGT

Robeco Institutional Asset Management's FLGT Position: Q3 2023 in Review

Robeco Institutional Asset Management sold out of Fulgent Genetics (FLGT) in Q3 2023, closing a stake of 20,765 shares — an estimated $769K sold.

Robeco Institutional Asset Management first reported a position in FLGT in Q3 2022 and held it in 4 quarters. The position peaked at $2.09M in Q1 2023. 201 funds tracked by Wall St. Rank hold FLGT as of Q3 2023.

  • Robeco Institutional Asset Management reported no remaining Fulgent Genetics position as of Q3 2023 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 20,765 Fulgent Genetics shares in Q3 2023, an estimated $769K.
  • Robeco Institutional Asset Management first reported a position in Fulgent Genetics in Q3 2022 and held it in 4 quarters.
  • Robeco Institutional Asset Management's Fulgent Genetics position peaked at $2.09M in Q1 2023.
  • 201 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2023, filed 24 Oct 2023.